Last reviewed · How we verify
NCT06746038
Evaluation of Extended Wear Hearing Aid for Mild Hearing Loss
NA trial testing Extended Wear Hearing Aid in Sensorineural Hearing Loss in 10 participants. Not yet recruiting.
15 March 2025
Quick facts
| Lead sponsor | Sonova AG |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 15 January 2025 |
| Primary completion | 15 March 2025 |
| Estimated completion | 15 March 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Extended Wear Hearing Aid
Conditions studied
- Sensorineural Hearing Loss — all drugs for Sensorineural Hearing Loss →
Sponsor
Sonova AG — full company profile →
Who can join
18 and older, any sex, with Sensorineural Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will assess the benefit of extended wear hearing aids for subjective listening effort, compared to the unaided condition, in adults with mild sensorineural hearing loss.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06746038
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sensorineural Hearing Loss
Currently open trials in the same condition.
- NCT07505667 — Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss · NA · recruiting
- NCT06507007 — Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome · recruiting
- NCT07364747 — Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial · Phase 2 · recruiting
- NCT06495268 — Healthy heaAring for Healthy Ageing: Data-driven Hearing Rehabilitation Intervention to Promote Healthy Hearing · NA · active not recruiting
- NCT06226558 — Long-Term Outcomes of Children With Congenital CMV in New York State · recruiting
Other Sonova AG trials
Trials by the same sponsor.
- NCT07526428 — Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment · NA · enrolling by invitation
- NCT07501312 — Remote Microphone Performance Comparison in Adults With Hearing Loss · NA · enrolling by invitation
- NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
- NCT06957730 — A Comparison of Hearing Aid Noise Programs on Speech Intelligibility · NA · completed
- NCT06710236 — Evaluation of Investigational Hearing Instrument Features · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06746038 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sonova AG
- Last refreshed: 24 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06746038.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing